Drug Discovery

Effort aligns MD Anderson’s drug development expertise with Exscientia’s AI-driven patient-first precision medicine and drug discovery platforms…

Agreement includes aggregate upfront and target nomination fees of up to $21.5 million for up to 6 targets, and additional R&D and sales…

Elix, and SEEDSUPPLY Inc. hereby announce the start of joint research. Latest Aithority Insights : Adobe Target Announces New AI-enriched…

GNS, the leader in the use of "Digital Twins" and Causal AI & biosimulation technology for biopharmaceutical drug discovery and development, and …

As digitization becomes a necessity in the life sciences industry, Gb Sciences proves it's already ahead of the curve with its own revolutionary…

Orion Biotechnology Canada Ltd, a drug discovery company targeting previously undruggable G Protein-Coupled Receptors (GPCRs), and Peptilogics, a…

Terray Therapeutics, a biotechnology company propelling drug discovery into the information age, announced the appointment of Fiona Black, PhD to its…

MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, and Mesh Bio, a digital health startup transforming chronic disease…

Aqemia, the next-gen pharmatech company leveraging artificial intelligence and quantum physics announced, that it has entered a new research…

- Collaboration poised to exploit synergistic drug discovery and development engine to enable innovation at scale by InveniAI and validation of…